S. Queener

J. Åqvist, A. Hallberg, K. Kolmodin, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.

S. Queener, A. Rosowsky, R. Forsch, 2002, Journal of medicinal chemistry.

2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.

J. J. Heusner, S. Queener, A. Rosowsky, 1993, Journal of medicinal chemistry.

Tricyclic 2,4-diaminopyrimidines with broad antifolate activity and the ability to inhibit Pneumocystis carinii growth in cultured human lung fibroblasts in the presence of leucovorin.

H. Lazarus, E. Modest, S. Queener, 1989, Biochemical pharmacology.

Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection

S F Queener, M. Durkin, S. Queener, 1987, Antimicrobial Agents and Chemotherapy.

Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent.

V. Cody, S F Queener, V Cody, 2000, Journal of medicinal chemistry.

Synthesis of three carbon atom bridged 2,4-diaminopyrrolo[2,3-d]-pyrimidines as nonclassical dihydrofolate reductase inhibitors

S. Queener, A. Gangjee, Zhengqu Ye, 2005 .

Novel 2,4-diamino-5-substituted furo[2,3-d]-pyrimidines as potential antifolates.

R. Devraj, S. Queener, A. Gangjee, 1993, Advances in experimental medicine and biology.

Brominated trimetrexate analogues as inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase

S. Queener, A. Rosowsky, C. E. Mota, 1996 .

Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.

S. Queener, A. Rosowsky, A. Papoulis, 1999, Journal of medicinal chemistry.

Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.

V. Cody, Sudhir Raghavan, S. Queener, 2013, Journal of medicinal chemistry.

The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents.

S. Queener, A. Gangjee, R. Kisliuk, 2008, Journal of medicinal chemistry.

Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.

S F Queener, S. Queener, A. Gangjee, 2001, Bioorganic & medicinal chemistry.

Structure-based design of selective inhibitors of dihydrofolate reductase: synthesis and antiparasitic activity of 2, 4-diaminopteridine analogues with a bridged diarylamine side chain.

V. Cody, S F Queener, A Rosowsky, 1999, Journal of medicinal chemistry.

Effect of N9-methylation and bridge atom variation on the activity of 5-substituted 2,4-diaminopyrrolo[2,3-d]pyrimidines against dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.

F. Mavandadi, S. Queener, A. Gangjee, 1997, Journal of medicinal chemistry.

Synthesis and dihydrofolate reductase inhibitory activities of 2,4-diamino-5-deaza and 2,4-diamino-5,10-dideaza lipophilic antifolates.

R. Devraj, S. Queener, A. Gangjee, 1997, Journal of medicinal chemistry.

Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.

S. Queener, C. Johnson, E. Pfefferkorn, 1996, Journal of medicinal chemistry.

Novel 2,4-diamino-5-substituted-pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolate inhibitors of dihydrofolate reductases.

F. Mavandadi, S. Queener, A. Gangjee, 1995, Journal of medicinal chemistry.

Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.

L. Barrows, S. Queener, A. Gangjee, 1993, Journal of medicinal chemistry.

Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase

S F Queener, S. Queener, L C Chio, 1993, Antimicrobial Agents and Chemotherapy.

Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs

S F Queener, S. Queener, M C Broughton, 1991, Antimicrobial Agents and Chemotherapy.

Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.

S. Queener, A. Rosowsky, R. Forsch, 2004, Bioorganic & medicinal chemistry letters.

2,4-Diamino-5-chloroquinazoline analogues of trimetrexate and piritrexim: synthesis and antifolate activity.

S F Queener, A Rosowsky, S. Queener, 1994, Journal of medicinal chemistry.

Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.

Xin Lin, S. Queener, A. Gangjee, 2004, Journal of medicinal chemistry.

2,4-Diaminothieno[2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.

S. Queener, A. Rosowsky, A. Papoulis, 1997, Journal of medicinal chemistry.

Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.

A. Vasudevan, S. Queener, A. Gangjee, 1997, Journal of medicinal chemistry.

Nonclassical 2,4-diamino-6-(aminomethyl)-5,6,7,8-tetrahydroquinazoline antifolates: synthesis and biological activities.

N. Zaveri, S. Queener, A. Gangjee, 1995, Journal of medicinal chemistry.

Synthesis and Biological Activities of Tetrahydroquinazoline Analogues of Aminopterin and Methotrexate.

N. Zaveri, S. Queener, A. Gangjee, 1995 .

Synthesis and anti-pneumocystis carinii activity of piperidine-linked aromatic diimidazolines

James W. Smith, Tien L. Huang, I. Donkor, 1996 .

Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium

M. Nasr, S. Queener, L. Chio, 1996, Antimicrobial agents and chemotherapy.

Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii

S. Queener, J. Smith, M. Bartlett, 1995, Antimicrobial agents and chemotherapy.

Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.

W. Milhous, S. Queener, J. Smith, 1992, The Journal of infectious diseases.

Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii

T. Edlind, M. Shaw, M. Durkin, 1992, Antimicrobial Agents and Chemotherapy.

8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models

W. Milhous, R. Tidwell, S. Queener, 1991, Antimicrobial Agents and Chemotherapy.

In vitro activities of acridone alkaloids against Pneumocystis carinii

Y. Nishiyama, S. Queener, J. Smith, 1991, Antimicrobial Agents and Chemotherapy.

Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).

J. Fishman, M. Durkin, S. Queener, 1990, Experimental parasitology.

New rat model of Pneumocystis carinii infection

J. Fishman, M. Durkin, S. Queener, 1988, Journal of clinical microbiology.

Novel boron-containing, nonclassical antifolates: synthesis and preliminary biological and structural evaluation.

S. R. Campbell, J. M. Riordan, R. Dixon, 2007, Journal of medicinal chemistry.

Structural studies on bioactive compounds. Part 36: design, synthesis and biological evaluation of pyrimethamine-based antifolates against Pneumocystis carinii.

Charles A Laughton, C. Laughton, M. Stevens, 2002, Bioorganic & medicinal chemistry.

2,4-Diaminopyrido[3,2-d]pyrimidine inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii.

S. Queener, A. Rosowsky, R. Forsch, 1995, Journal of medicinal chemistry.

Synthesis of 2,4-diamino-6-[2'-O-(omega-carboxyalkyl)oxydibenz[b,f]azepin-5-yl]methylpteridines as potent and selective inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase.

S. Queener, A. Rosowsky, D. Chan, 2004, Journal of medicinal chemistry.

Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.

V. Cody, J. Luft, W. Pangborn, 1998, Journal of medicinal chemistry.

Beta-lactam antibiotics for clinical use

S. Queener, S. Queener, J. Webber, 1986 .

Cardiac adenylate cyclase: kinetics of synergistic activation by guanosine-5'-triphosphate (GTP) and glucagon.

C. M. Clark, S. Queener, R. Fricke, 1980, Journal of molecular and cellular cardiology.

Metabolic imbalance in carbohydrate, pyrimidine and ornithine utilization.

G. Dunaway, G. Weber, S. Queener, 1972, Advances in enzyme regulation.

Improved rat model for studying Pneumocystis carinii pneumonia

M. Durkin, S. Queener, J. Smith, 1987, Journal of clinical microbiology.

Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.

V. Cody, J. Luft, W. Pangborn, 2000, Biochemistry.

Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes

M. Leibowitz, M. Shaw, S. Queener, 1994, Journal of clinical microbiology.

Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimens.

Ja Lu, S. Queener, J. Smith, 1995, The Journal of infectious diseases.

Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.

V. Cody, S. Queener, A. Gangjee, 2019, Bioorganic & medicinal chemistry letters.

Sources of rats free of latent Pneumocystis carinii

M. Durkin, S. Queener, J. Smith, 1987, Journal of clinical microbiology.

Types of Pneumocystis carinii Detected in Air Samples

P. J. Durant, S. Queener, J. Smith, 1996, The Journal of eukaryotic microbiology.

Incorporation of Fatty Acids and Amino Acids by Cultured Pneumocystis carinii

S. Queener, J. Paulsrud, 1994, The Journal of eukaryotic microbiology.

Conformationally restricted tricyclic analogues of lipophilic pyrido[2,3‐d]pyrimidine antifolates

F. Mavandadi, S. Queener, A. Gangjee, 2001 .

Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase

S F Queener, A Rosowsky, J B Hynes, 1995, Antimicrobial agents and chemotherapy.

Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model

J. Fishman, S. Queener, M. Bartlett, 1993, Antimicrobial Agents and Chemotherapy.

Demonstration of Esterase Activity in Pneumocystis carinii by Cleavage of 4‐Methylumbelliferyl Substrates

P. J. Durant, M. Shaw, S. Queener, 1996, The Journal of eukaryotic microbiology.

Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice

T. Edlind, M. Shaw, S. Queener, 1994, Antimicrobial Agents and Chemotherapy.

Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.

Vivian Cody, V. Cody, J. Luft, 2004, Acta crystallographica. Section D, Biological crystallography.

The synthesis of new 2,4‐diaminofuro[2,3‐d]pyrimidines with 5‐biphenyl, phenoxyphenyl and tricyclic substitutions as dihydrofolate reductase inhibitors

S. Queener, A. Gangjee, N. Dubash, 2000 .

Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.

S. Queener, A. Gangjee, Y. Zhu, 1996, Journal of Medicinal Chemistry.

Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in behavior of L-ornithine carbamyl transferase activity.

H. Morris, G. Weber, S. Queener, 1972, Cancer research.

Synthesis of 2,4‐diaminopyrido[2,3‐d]pyrimidines and 2,4‐diamino‐quinazolines with bulky dibenz[b,f]azepine and dibenzo[a,d]‐cycloheptene substituents at the 6‐position as inhibitors of dihydrofolate reductases from pneumocystis carinii, toxoplasma gondii, and mycobacterium avium

S. Queener, A. Rosowsky, H. Fu, 2000 .

Lipophilic antifolates as candidates against opportunistic infections.

S. Queener, C. Johnson, E. Pfefferkorn, 1993, Advances in experimental medicine and biology.

The Synthesis of New 2,4‐Diaminofuro[2,3‐d]pyrimidines with 5‐Biphenyl, Phenoxyphenyl and Tricyclic Substitutions as Dihydrofolate Reductase Inhibitors.

S. Queener, A. Gangjee, N. Dubash, 2001 .

Activity of inosine analogs against Pneumocystis carinii in culture

R. Klein, J. Marr, S. Queener, 1986, Antimicrobial Agents and Chemotherapy.

Pteroylpolyglutamate synthesis by lung- and culture-derived Pneumocystis carinii.

S. Meshnick, S. Queener, J. Smith, 1995, FEMS microbiology letters.

Purification and characterization of human-derived Pneumocystis jirovecii dihydrofolate reductase expressed in Sf21 insect cells and in Escherichia coli.

V. Cody, S. Queener, C. Pope, 2005, Protein expression and purification.

Inhibitors of eIF2α Dephosphorylation Slow Replication and Stabilize Latency in Toxoplasma gondii

R. Wek, W. Sullivan, S. Queener, 2013, Antimicrobial Agents and Chemotherapy.

Phosphorylation of eukaryotic initiation factor-2α promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii

R. Wek, Bradley R. Joyce, W. Sullivan, 2010, Proceedings of the National Academy of Sciences.

Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.

R. Neiman, S. Queener, J. Smith, 1994, Clinical and diagnostic laboratory immunology.

Targeting species specific amino acid residues: Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors and potential anti-opportunistic infection agents.

V. Cody, Xin Lin, S. Queener, 2018, Bioorganic & medicinal chemistry.

Differential splicing of Pneumocystis carinii f. sp. carinii inosine 5'-monophosphate dehydrogenase pre-mRNA.

S. Queener, C. H. Lee, D. Ye, 2001, Gene.

An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivo

M. Shaw, M. Durkin, S. Queener, 1992, Journal of clinical microbiology.

Pneumocystis carinii is resistant to imidazole antifungal agents

M. Shaw, S. Queener, J. Smith, 1994, Antimicrobial Agents and Chemotherapy.

Pentobarbital sleeping time and waking blood levels in spontaneously hypertensive rats.

L. R. Willis, S. Queener, 1977, Canadian journal of physiology and pharmacology.

Stimulation of calcitonin synthesis and release in vitro by calcium and dibutyryl cyclic AMP

N. Bell, S. Queener, 1974, Nature.

DHFR and IMPDH: Enzymes exploitable as drug targets in pneumocystis

S. Queener, 2004 .

Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase.

V. Cody, S. Queener, J. Pace, 2011, Journal of structural biology.

Diversifying Biomedical Training: A Synergistic Intervention.

J. Foertsch, H. Broxmeyer, M. Sturek, 2010, Journal of Women and Minorities in Science and Engineering.

Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.

W Pangborn, A. Vasudevan, V. Cody, 1998, Journal of medicinal chemistry.

Inoculated mouse model of Pneumocystis carinii infection.

M. Durkin, S. Queener, J. Smith, 1992, Diagnostic microbiology and infectious disease.

Comparison ofCorticosteroid- andL3T4+Antibody- Immunosuppressed MouseModels ofPneumocystis carinii Pneumonia forEvaluation ofDrugsandLeukocytes

S. Queener, Nancy L. Bauer, 1994 .

Synthesis and DHFR inhibitory activity of a series of 6-substituted-2,4-diaminothieno[2,3-d]pyrimidines.

I. Donkor, S. Queener, Hui Li, 2003, European journal of medicinal chemistry.

Simultaneous determination of primaquine and carboxyprimaquine in plasma using high-performance liquid chromatography with electrochemical detection.

S. Queener, R. Dean, M. Bartlett, 1994, Journal of chromatography. B, Biomedical applications.

Binary fission of Pneumocystis carinii trophozoites grown in vitro.

S. Queener, J. Smith, J. Richardson, 1989, The Journal of protozoology.

Comparison of the regulation of calcitonin in serum of old and young Buffalo rats.

E. Slatopolsky, N. Bell, D. Henry, 1980, The Journal of endocrinology.

Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii.

M. Shaw, S. Queener, J. Smith, 1993, International journal of experimental pathology.

The effect of primaquine on the ultrastructural morphology of Pneumocystis carinii.

S. Queener, J. Smith, M. Bartlett, 1991, The Journal of protozoology.

Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.

V. Cody, S. Queener, A. Rosowsky, 2009, Biochemistry.

Design, synthesis and biological evaluation of 2,4‐diamino‐6‐methyl‐5‐substitutedpyrrolo[2,3‐d]pyrimidines as dihydrofolate reductase inhibitors

S. Queener, A. Gangjee, H. D. Jain, 2005 .

7-Methyl trimethoprim analogues as inhibitors of the folate metabolizing enzymes

Xin Lin, S. Queener, A. Gangjee, 2003 .

7-Methyl Trimethoprim Analogues as Inhibitors of the Folate Metabolizing Enzymes.

Xin Lin, S. Queener, A. Gangjee, 2003 .

Design, Synthesis and Biological Evaluation of 2,4‐Diamino‐6‐methyl‐5‐substituted‐pyrrolo[2,3‐d]pyrimidines as Dihydrofolate Reductase Inhibitors.

S. Queener, A. Gangjee, H. D. Jain, 2005 .

Kinetic and Structural Analysis for Potent Antifolate Inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and Human Dihydrofolate Reductases and Their Active-Site Variants

V. Cody, S. Queener, A. Gangjee, 2013, Antimicrobial Agents and Chemotherapy.

Bicyclic conformationally restricted analogs of nonclassical pyrido[2,3-d] pyrimidines as potential inhibitors of dihydrofolate reductases.

A. Vasudevan, S. Queener, A. Gangjee, 1993, Advances in Experimental Medicine and Biology.

New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.

C. Inderlied, C. Sibley, S. Queener, 2004, Journal of medicinal chemistry.

Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens.

N. Tawari, S. Queener, M. Degani, 2010, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms

N. Tawari, S. Queener, M. Degani, 2010, Journal of enzyme inhibition and medicinal chemistry.

Recombinant bovine dihydrofolate reductase produced by mutagenesis and nested PCR of murine dihydrofolate reductase cDNA.

V. Cody, S. Queener, Q. Mao, 2008, Protein expression and purification.

Effects of diabetes mellitus on renal fatty acid activation and desaturation.

D. Clark, S. Queener, 1985, Biochemical pharmacology.

2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.

M. Waltham, E. Ercikan-Abali, J. Bertino, 1995, Journal of medicinal chemistry.

Selective Antifolates for Chemically Labeling Proteins in Mammalian Cells

Lawrence W. Miller, S. Queener, Laura E Pedró Rosa, 2009, Chembiochem : a European journal of chemical biology.

Total cellular fatty acid composition of cultured Pneumocystis carinii

S. Queener, J. Smith, M. Bartlett, 1993, Journal of clinical microbiology.

Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections.

K. Anderson, S. Queener, A. Gangjee, 2013, ACS medicinal chemistry letters.

N,N'-bis[4-(N-alkylamidino)phenyl]homopiperazines as anti-Pneumocystis carinii agents.

I. Donkor, S. Queener, T. Huang, 2001, Bioorganic & medicinal chemistry letters.

Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprine.

V. Cody, S F Queener, A Rosowsky, 1999, Drug design and discovery.

6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.

S. Queener, A. Gangjee, Y. Zhu, 1998, Journal of Medicinal Chemistry.

Structural studies on bioactive compounds. 28. Selective activity of triazenyl-substituted pyrimethamine derivatives against Pneumocystis carinii dihydrofolate reductase.

M. Stevens, P. Lambert, S. Queener, 1997, Journal of Medicinal Chemistry.

N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase.

S. Queener, A. Gangjee, O. Adair, 2008, Journal of medicinal chemistry.

Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.

S. Queener, A. Rosowsky, R. Forsch, 2003, Journal of medicinal chemistry.

In Vitro and In Vivo Models of Pneumocyustis carinii

P. J. Durant, James W. Smith, M. Shaw, 1997 .

An improved rat model to study efficacy of drugs for treatment or prophylaxis of Pneumocystis carinii pneumonia.

J. Fishman, M. Durkin, S. Queener, 1989, The Journal of Protozoology.

Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks

M. Shaw, M. Durkin, S. Queener, 1993, Journal of clinical microbiology.

fromWalter ReedArmyInstitute forResearch forTreatment andProphylaxis of Pneumocystis Pneumonia inRatModels

W. Milhous, James W. Smith, R. Tidwell, 1991 .

2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase.

F. Mavandadi, S. Queener, A. Gangjee, 1996, Journal of Medicinal Chemistry.

2-Amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines as Nonclassical Antifolate Inhibitors of Thymidylate Synthase.

F. Mavandadi, S. Queener, A. Gangjee, 1997, Journal of medicinal chemistry.

Solubilization of calcitonin-responsive renal cortical adenylate cyclase.

J. W. Fleming, N. Bell, S. Queener, 1975, The Journal of biological chemistry.

Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductases.

S. Queener, A. Gangjee, Anil Vasudevan, 1997, Journal of medicinal chemistry.

Anthranilate synthase enzyme system and complementation in Pseudomonas species.

I. C. Gunsalus, S. Queener, 1970, Proceedings of the National Academy of Sciences of the United States of America.